PORT WASHINGTON, N.Y., September 19, 2012 -
Pall Corporation (NYSE:PLL),
a global leader in filtration, separation and purification, today
announced it will be opening a state-of-the-art Life
Sciences Center of Excellence in Westborough, Massachusetts.
Strategically located in the heart of Massachusetts’ renowned
life-science cluster, the new center will provide Pall life sciences
customers in the northeast region of the United States a range of
process solutions for drug development, validation support and training
capabilities. The new Life Sciences center is scheduled to open in the
spring of 2013.
“Our New England Life Sciences Center of Excellence is an important
addition to our global network of customer support centers,” said Ken
Frank, President, Pall BioPharmaceuticals. “It will complement our new
center in Menlo Park, Calif. and serve as a technical hub for our Life
Sciences business and operations in the northeast region of the United
The 113,000 square-feet center will be equipped with new advanced life
sciences equipment and will serve as a showcase for Pall technologies.
These include: single-use systems (SUS), tangential flow filtration
(TFF) systems, viral clearance and cell culture solutions,
chromatography systems and others. The Westborough complex will serve as
a proving ground for new technologies and applications development and
will be designed to lead customers through the sequential stages of
process flow. The center also will serve as a training facility for both
Pall employees and customers.
Pall plans to transfer its existing operations and employees from its
Northborough, Massachusetts location to the new center.
“The new Westborough facility provides an excellent opportunity for
growth and will allow us to retain and attract talented scientists and
engineers from the New England area,” adds Frank.
Pall Life Sciences
Pall Life Sciences provides cutting-edge products and services to meet
the demanding needs of customers discovering, developing and producing
biotech drugs, vaccines and classic pharmaceuticals. The company’s
membranes and membrane devices optimize detection and sample preparation
in the drug research, clinical diagnostics, genomics, and proteomics
markets. Pall is a leading provider of separation systems and single-use
filtration and purification technologies to pharmaceutical and
biotechnology companies to support faster development of new drugs and
vaccines that are safer and require less energy and water to produce.
Pall technologies are also used in clinical institutions and the food
and beverage industries.
About Pall Corporation
Pall Corporation (NYSE:PLL)
is a filtration, separation and purification leader providing solutions
to meet the critical fluid management needs of customers across the
broad spectrum of life sciences and industry. Pall works with customers
to advance health, safety and environmentally responsible technologies.
The Company’s engineered products enable process and product innovation
and minimize emissions and waste. Pall Corporation is an S&P 500 company
serving customers worldwide. Pall has been named a “top green company”
by Newsweek magazine. To see how Pall is helping enable a
greener, safer, more sustainable future, follow us on Twitter @PallCorporation
or visit www.pall.com/green.
Pall Corporation Doug Novarro Corporate Public Relations 5168019944 Follow
us on Twitter @pallcorporation